López-Verdín S, Martínez-Fierro ML, Garza-Veloz I, Zamora-Perez A, Grajeda-Cruz J, González-González R, Molina-Frechero N, Arocena- Sutz M, Bologna-Molina R. E-Cadherin gene expression in oral cancer: Clinical and prospective data. Med Oral Patol Oral Cir Bucal. 2019 Jul 1;24 (4):e444-51.
doi:10.4317/medoral.23029
http://dx.doi.org/doi:10.4317/medoral.23029
_______________________________________________________________________________________________________________________________________________________________________________________
References
|
1. Bray F. Transitions in human development and the
global cancer burden. In: Wild CP, Stewart B (ed). World cancer report 2014.
Lyon: International Agency for Research on Cancer. 2014;23-44. |
|
|
|
|
|
2.Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers
C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources,
methods and major patterns in GLOBOCAN 2012. Int J Cancer.
2012;136:E359-E386. |
|
|
|
|
|
3. Fernandes A, Pinto F, Shien L, Vamondes M, Cernea C. Oral cavity squamous cell carcinoma: factors related to occult lymph node metastasis. Brazilian Journal of Otorhinolaryngology. 2015;130:1-7. |
|
|
|
|
|
4.Brennan M, Migliorati CA, Lockhart PB, Wray D,
Al-Hashimi I, Axéll T, Bruce AJ, et al. Management of oral epithelial
displasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2007;103:e1-e12. |
|
|
|
|
|
5. Massano J, Regateiro FS, Januario G, Ferreira A.
Oral squamous cell carcinoma: review of prognostic and predictive factors.
Oral Surg Oral Med Oral Patho Oral Radiol Endod. 2006;103:67-76. |
|
|
|
|
|
6. Berx G, van Roy F. Involvement of Members of the
Cadherin Superfamily in Cancer. Cold Spring HarbPerspectBiol. 2009;1:a0031. |
|
|
|
|
|
7. Lau MT, Klausen C and Leung PCK. E-cadherin inhibits
tumor cell growth by suppressing PI3K/Akt signaling via
β-catenin-Egr1-mediated PTEN expression. Oncogene. 2011;30:2753-2766. |
|
|
|
|
|
8. Barrallo-Gimeno A, Nieto MA. The Snail genes as
inducers of cell movement and survival: implications in development and
cancer. Development. 2005;132:3151-3161. |
|
|
|
|
|
9.Caberg JH, Hubert PM, Begon DY, Herfs MF, Roncarati
PJ, et al. Silencing of E7 oncogene restores functional E-cadherin expression
in human papillomavirus 16-transformed keratinocytes. Carcinogenesis.
2008;29:1441-1447. |
|
|
|
|
|
10. Cobaleda C, Perez-Caro M, Vicente-Dueñas C,
Sánchez-García I. Function of the zinc-finger transcription factor SNAI2 in
cáncer and development. Annu Rev Genet. 2007;41:41-61. |
|
|
|
|
|
11.Mattijssen V, Peters H, Schalkwijk L, Manni JJ,
vant't Hof-Grootenboer B, de Mulder PH, et al. E-cadherin expression in head
and neck quamous cell carcinomas is associated with clinical outcome.
International Journal of Cancer. 1993;55:580-585. |
|
|
|
|
|
12. Diniz-Freitas Márcio, García-Caballero Tomás,
Antúnez-López José, Gándara-Rey José Manuel, García-García Abel. Reduced
E-cadherin expresión is an indicator of unfavourable prognosis in oral
squamous cell carcinoma. Oral Oncology. 2006;42:190-200. |
|
|
|
|
|
13. Zhao Z, Ge J, Sun Y, Tian L, Lu J, Liu M and Zhao
Y. Is E-cadherina inmunoexpression a prognostic factor for head and neck
squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis. Oral
Oncology. 2012;48:761-767. |
|
|
|
|
|
14. Jia-Yo W, Chen Y, Ho-Ren C, Duen-Jeng W, Wen-Chien
C, Sheng-Yang L, et al. Potential biomarkers in saliva for oral squamous cell
carcinoma. Oral Oncology. 2010;46:226-231. |
|
|
|
|
|
15. Yuwanati MB, Tupkari JV, Avadhani A. Expression of
E-cadherin in oral epithelial dysplasia and oral squamous cell carcinoma: An
in vivo study. Journal of Clinical and Experimental Investigations.
2011;2:347-353. |
|
|
|
|
|
16. Andrews NA, Jones AS, Helliwell TR and Kinsella AR.
Expression of the E-cadherin-catenin cell adhesion complex in primary
squamous cell carcinomas of the head and neck and their nodal metastases.
Britishh Journal of Cancer. 1997;75:1474-1480. |
|
|
|
|
|
17.Tanaka N, Odajma T, Ogi K, Ikeda T, and Satoh M. Expression
of E-cadherin, α-catenin and β-catenin in the process of lymph node
metastasis in oral squamous cell carcinoma. British Journal of Cancer.
2003;89:557-563. |
|
|
|
|
|
18.Wang X, Zhang J, Mingwen F, Zhou Q, Deng H, Aisharif
MJ, et al. The expression of E-cadherin at the invasive tumor front of oral
suqamous cell carcinoma: inmunohistochemical and RT-PCR analysis with clinicopathological
correlation. Oral Surg Oral Med Oral Path Oral RadiolEndod. 2009;107:547-554. |
|
|
|
|
|
19. Rosado P, Leuqerica-Fernández P, Fernández S,
Allonca E, Villallaín L, de Vicente JC. E-cadherin and β-catenin expression
in well-differentiated and moderately differentiated oral squamous cell
carcinoma: relation with clinical variables. Br J Oral MaxillofacialSurg. 2013;51:149-56. |
|
|
|
|
|
20.Sasaya K, Sudo H, Maeda G, Kawashiri S and Imai K.
Concomitant Loss of p120-Catenina and β-catenin Membrane Expression and Oral
Carcinoma Progression with E-cadherin Reduction. PLOS ONE. 2013;8:e69777. |
|
|
|
|
|
21.Pectasides E, Rampias T, Sasaki C, Perisanidis C,
Kouloulias V, Burtness B, et al. Markers of Epithelial to Mesenchymal
Transition in Association with Survival in Head and Neck Squamous Cell
Carcinoma (HNSCC). PLOS One. 2014;9:e94273. |
|
|
|
|
|
22. Jiang Y, Liao L, Shrestha C, Ji S, Chen Y, Peng J, et al. Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC- γ1 and PIKE are associated with aggressiveness of oral squamoous cell carcinoma. Int J Clin Exp Pathol. 2015;8:9042-9051. |
|
|
|
|
|
23. Yao X, Sun S, Zhou X, Zhang Q, Guo W, Zhang L.
Clinicopathological significance of ZEB-I and E-cadherin proteins in patients
qith oral cavity squamous cell carcinoma. OncoTargets and Therapy.
2017;10:781-790. |
|
|
|
|
|
24. Meyerson M, Gabriel S, Gets G. (Advances in
understanding cáncer genomes through second-generation sequencing. Nature
Reviews Genetics. 2010;11:685-96. |
|
|
|
|
|
25. AJCC: Lip and Oral cavity. En: Edge SB, Byrd DR,
Compton CC, et al., 7th eds. En: AJCC Cancer Staging Manual. 8th ed. New
York, NY: Springer, 2010, pp 29-40 |
|
|
|
|
|
26. National Cancer Institute available in https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci accessed August 19, 2016. |
|
|
|
|
|
27. DeSouza M, Weslley P, Calsolari M. Persistent and
recurrent disease in ptient with papillary thyroid carcinoma with clinically
apparent (cN1), but no extensive, lymph node involvement and without other
factors for por prognosis Arch Endocrinol Metab. 2015;59:285-291. |
|
|
|
|
|
28. Greene F, Page D, Fleming I, et al., AJCC Cancer Staging Hadbook Colon and rectum. New York: Springer. 2003 pp127-138 |
|
|
|
|
|
29. Hanahan D, Weinberg R. Hallmarks of cancer. The
next generation. Cell. 2011;144:646-674. |
|
|
|
|
|
30. Olmeda D, Montes A, Moreno-Bueno G, Flores JM,
Portillo F, et al. Snai1 and Snai2 collaborate on tumor growth and metastasis
properties of mouse skin carcinoma cell lines. Oncogene 2008;27:4690-4701. |
|
|
|
|
|
31. Sobral LM, Sousa LO, Coletta RD, Cabral H, Greene
LJ, Tajara EH, et al. Stable SET knockdown in head and neck squemous cell
carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro,
as well as necrosis, cisplatin sensitivity and lymph node metastasis in
xenograft tumor models. Molecular Cancer. 2014;13:32. |
|
|
|
|
|
32.Tamagawa S, Beder LB, Hotomi M, Gunduz M, Yata K,
Grenmar R, et al. Role of miR-200c/miR-141 in the regulation of
epithelial-mesenchymal transition and migration in head and neck squamous
cell carcinoma. Int J MoL Med. 2014;33:879-86. |
|
|
|
|
|
33.
Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a
key regulator of the epithelial mesenchymal transition. Mol Cell Biol.
2001;21:8184-8. |
|
|
|
|
|
34.
Subbaiah VK, Kranjec C, Thomas M, Banks L. PDZ domains: the building blocks
regulating tumorigenesis. Biochem J. 2011;439:195-205. |
|
|
|
|
|
35.
D'Costa ZJ, Leong CM, Shields J, Matthews C, Hibma MH. Screening of drugs to
counteract human papillomavirus 16 E6 repression of E-cadherinexpression.
Invest New Drugs. PLOS one. 2012;7:e48954. |
|
|
|
|
|
36. Al
Moustafa AE, D Foulkes W, Benliname N, Wong A, Yen L, Bergeron J, et al.
E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic
transformation of primary normal oral epithelial cells. Oncogene.
2004;23:350-8. |
|
|
|
|
|
37.
Wang C, Liu X, Chen Z, Huang H, Jin Y, Kolokythas A, et al. Polycomb group
protein EZH2-mediated E-cadherin repression promotes metastasis of oral
tongue squamous cell carcinoma. MolCarcinog. 2013;52:229-236. |
|